NON-RHEUMATIC MYOCARDITIDES
https://doi.org/10.17650/1818-8338-2015-9-3-46-51
Abstract
Myocarditis is an inflammatory disease of the myocardium, which is caused by different factors, such as infectious, immune, chemical, physical, and allergic ones. The main cause of the disease is viral agents. In 1837, the term “myocarditis” was introduced in medical prac tice by J.F. Sobernheim who considered the presence of an infectious agent and inflammatory and vascular disorders in the myocardium to be the major signs of the disease. The specific symptoms of myocarditis cannot be identified therefore it is rather hard to determine the prevalence of the disease in the population. However, the association with a definite etiological factor (such as with prior infection and use of some drugs) and the presence of the symptoms of myocardial lesion (chest pain, dyspnea, rhythm and conduction disturbances) may sug gest an idea on the possible development of myocarditis. Laboratory studies show an elevation of cardiospecific enzymes and the signs of an inflammatory response. Endomyocardial biopsy (EMB) is the gold standard for the diagnosis of myocarditis to the present day. The diag nostic value of the method is limited by technical feasibilities, the skills of medical staff, and the development of possible complications. Gadolinium magnetic resonance imaging that can visualize myocardial inflammatory foci may be used as an alternative to EMB. The de veloped criteria are of definite diagnostic value; however, the problems in making diagnosis and differential diagnosis remain unsolved. There are no specific myocarditis treatment methods and regimens. Symptomatic therapy is most commonly used depending on the existing manifestations of myocarditis. The intake of nonsteroidal antiinflammatory drugs and glucocorticosteroids is now a point open to question. It is necessary to remember about the prevention of infectious myocarditis and the sanitization of existing foci of infection in the body.
Keywords
About the Authors
N. A. ShostakRussian Federation
A. A. Klimenko
Russian Federation
V. S. Shemenkova
Russian Federation
T. K. Loginova
Russian Federation
References
1. Kindermann I., Barth C., Mahfoud F. et al. Update on myocarditis. J Am Coll Cardiol 2012;59(9):779–92.
2. Палеев Н.Р., Палеев Ф.Н., Санина Н.П. Миокардиты. Альманах клинической медицины 2004;(7):118–26. [Paleev N.R., Paleev F.N., Sanina N.P. Myocarditis. Almanakh Klinicheskoy meditsiny = Clinical Medical Anthology 2004;(7):118–26. (In Russ.)].
3. Caforio A.L., Pankuweit S., Arbustini E. et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013;34(33):2636–48, 2648a–2648d.
4. Миокардиты. В кн.: Руководство по неишемической кардиологии. Под ред. проф. Н.А. Шостак. М.: ГЭОТАР-Медиа, 2009. С. 254–277. [Мyocarditis. In the book: Nonischemic cardiology guide. Edited by prof. N.А. Shostak. М.: GEOTAR-Меdia, 2009. P. 254–277. (In Russ.)].
5. Гиляревский С.Р. Миокардиты: современные подходы к диагностике и лечению. М.: Медиа Сфера, 2008. [Guilyarevlsy S.R. Мyocarditis: modern approaches to diagnosis and treatment. М.: Меdia Sphera, 2008. (In Russ.)].
6. JCS Joint Working Group. Guidelines for diagnosis and treatment of myocarditis (JCS 2009): digest version. Circ J 2011; 75(3):734–43.
7. Cooper L.T. Jr. Myocarditis. N Engl J Med 2009;360(15):1526–38.
8. Metzger T.C., Anderson M.S. Myocarditis: a defect in central immune tolerance? J Clin Invest 2011;121(4):1251–3.
9. Elamm C., Fairweather D., Cooper L. Republished: pathogenesis and diagnosis of myocarditis. Postgrad Med J 2012;88(1043):539–44.
10. Matsumori A. Lessons learned from experimental myocarditis. Herz 2012;37:817–21. 11. Theisen D., Reiser M.F. Cardiomyopathies and myocarditis. Radiologe 2013;53(1):7.
11. Shammas N.W., Padaria R.F., Coyne E.P. Pericarditis, myocarditis, and other cardiomyopathies. Prim Care 2013;40(1):213–36.
12. Thambidorai S.К., Korlakunta H.L., Arouni A.J. et al. Acute eosinophilic myocarditis mimicking myocardial infarction. Tex Heart Inst J 2009;36(4):355–7.
13. Amini R., Nielsen C. Eosinophilic myocarditis mimicking acute coronary syndrome secondary to idiopathic hypereosinophilic syndrome: a case report. J Med Case Rep 2010;4:40.
14. Yajima T. Viral myocarditis: potential defense mechanisms within the cardiomyocyte against virus infection. Future Microbiol 2011;6(5):551–66.
15. Jeserich M., Konstantinides S., Pavlik G. et al. Non-invasive imaging in the diagnosis of acute viral myocarditis. Clin Res Cardiol 2009;98(12):753–63.
16. Dennert R., Crijns H.J., Heymans S. Acute viral myocarditis. Eur Heart J 2008;29(17):2073–82.
17. Hsiao J.F., Koshino Y., Bonnichsen C.R. et al. Speckle tracking echocardiography in acute myocarditis. Int J Cardiovasc Imaging 2013;29(2):275–84.
18. Eisenberg M.A., Green-Hopkins I., Alexander M.E., Chiang V.W. Cardiac troponin T as a screening test for myocarditis in children. Pediatr Emerg Care 2012;28(11):1173–8.
19. Izumi T., Nishii M. Diagnostic and prognostic biomarkers in acute myocarditis. Interleukin-10. Herz 2012;37(6):627–31.
20. Sertogullarindan B., Ozbay B., Gumrukcuoglu H.A. et al. A case of viral myocarditis presenting with acute asthma attack. J Clin Med Res 2012;4(3):224–6.
21. Li H.S., Ligonsa D.L., Rosea N.R. Genetic complexity of autoimmune myocarditis. Autoimmun Rev 2008;7(3):168–73.
22. Caforio A.L., Marcolongo R., Jahns R. et al. Immune-mediated and autoimmune myocarditis: clinical presentation, diagnosis and management. Heart Fail Rev 2013;18(6):715–32.
23. Noutsias M., Patil V.J., Maisch B. Cellular immune mechanisms in myocarditis. Herz 2012;37(8):830–5.
24. Skurk C., Schultheiss H.P. Mononuclear cell secretome in autoimmune myocarditis. Eur Heart J 2015;36(11):650–2.
25. Friedrich M.G., Sechtem U., Schulz-Menger J. et al. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol 2009;53(17):1475–87.
26. Kim E.Y., Chang S.A., Lee Y.K. et al. Early non-invasive diagnosis and treatment of acute eosinophilic myopericarditis by cardiac magnetic resonance. J Korean Med Sci 2011;26(11):1522–6.
27. Stensaeth K.H., Hoffmann P., Fossum E. et al. Cardiac magnetic resonance visualizes acute and chronic myocardial injuries in myocarditis. Int J Cardiovasc Imaging 2012;28(2):327–35.
28. Maisch B., Pankuweit S. Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives. Heart Fail Rev 2012;18(6):761–95.
29. McCarthy R.E. 3rd, Boehmer J.P., Hruban R.H. et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000;342(10):690–5.
30. Lee C., Tsai W., Hsu C. et al. Predictive factors of a fulminant course in acute myocarditis. Int J Cardiol 2006;109(1):142–5. 32. Magnani J.W., Danik H.J., Dec G.W. Jr., DiSalvo T.G. Survival in biopsy-proven myocarditis: a long-term retrospective analysis of the histopathologic, clinical, and hemodynamic predictors. Am Heart J 2006;151(2):463–70.
Review
For citations:
Shostak N.A., Klimenko A.A., Shemenkova V.S., Loginova T.K. NON-RHEUMATIC MYOCARDITIDES. The Clinician. 2015;9(3):46-51. (In Russ.) https://doi.org/10.17650/1818-8338-2015-9-3-46-51